Could happen that way. I suspect investors are concerned about the company taking on debt to fund day to day expenses. Essentially it is committing the company to profitability based on the CEO's schedule. Its more "risky" than an equity raising, but it does guarantee the cash will be there.
If all goes according to the CEO's promise anybody buying at this price is probably getting a bargain.
Immunotherapy Partner Patrick Soon Shiong, page-23
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.62 |
Change
0.020(0.11%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.62 | $18.62 | $18.62 | $8.845K | 475 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2182 | $18.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.70 | 100 | 1 |
View Market Depth
| Last trade - 10.00am 24/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |